BioTech 365

NOVEMBER 29, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Turnstone teams up with Moffitt to race TIL cell therapies into the clinic.Turnstone teams up with Moffitt to race TIL cell therapies into the clinic ntaylor Mon, … Continue reading →

Research 40

Research 40

BioTech 365

JANUARY 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Engineered stem cells that evade immune detection could boost cell therapy and I-O.Engineered stem cells that evade immune detection could boost cell therapy and I-O arlene.weintraub Fri, … Continue reading →

Engineer 40

Engineer Research 40

BioTech 365

NOVEMBER 3, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Cell and gene therapy specialist Minaris expanding. from European Biotechnology – first and foremost in European biotech [link].

Gene Therapy 40

Gene Therapy Gene Research 40

BioTech 365

AUGUST 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: T-knife bags $110M for raft of cell therapy solid tumor trials.T-knife

Trials 40

Trials Research 40

BioTech 365

DECEMBER 7, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara.After boosting gene therapy focus, Bayer signs up to new cell therapy pact … Continue reading →

Gene Therapy 40

Gene Therapy Gene Research 40

BioTech 365

SEPTEMBER 15, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol Myers exercises option on Obsidian’s CD40L cell therapy .Bristol

Research 40

Research 40

BioTech 365

MAY 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Esco raises $200M to set up Boston cell and gene therapy hub.Esco raises $200M to set up Boston cell and gene therapy hub ntaylor Wed, 05/26/2021 – … Continue reading →

Gene Therapy 40

Gene Therapy Gene Research 40

BioTech 365

NOVEMBER 20, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis licenses phase 3 COVID-19 cell therapy from Mesoblast.Novartis licenses phase 3 COVID-19 cell therapy from Mesoblast ntaylor Fri, 11/20/2020 – 06:47 from FierceBiotech: Biotech [link].

Licensing 40

Licensing Licensing Research 40

BioTech 365

DECEMBER 2, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bayer creates cell and gene therapy platform to support partners.Bayer creates cell and gene therapy platform to support partners ntaylor Wed, 12/02/2020 – 05:29 from FierceBiotech: Biotech … Continue reading → (..)

Gene Therapy 40

Gene Therapy Gene Research 40

BioTech 365

JULY 9, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FDA puts Sigilon’s hemophilia cell therapy trial on hold thanks to safety concerns.FDA puts Sigilon’s hemophilia cell therapy trial on hold thanks to safety concerns aalidrus Fri, … Continue reading →

Trials 40

Trials Research 40

BioTech 365

SEPTEMBER 10, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop.Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop … Continue reading →

Research 40

Research 40

BioTech 365

NOVEMBER 4, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Treating multiple sclerosis with an antigen-specific cell therapy.Treating multiple sclerosis with an antigen-specific cell therapy aliu Wed, 11/04/2020 – 06:51 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

JULY 9, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: J&J, Vor ally to assess bispecific and stem cell therapy in AML.J&J,

Research 40

Research 40

BioTech 365

NOVEMBER 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0.Bristol Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0 … Continue reading →

Research 40

Research 40

BioTech 365

FEBRUARY 16, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bluebird stops gene therapy trials after 2 sickle cell patients develop cancer.Bluebird stops gene therapy trials after 2 sickle cell patients develop cancer ntaylor Tue, 02/16/2021 – … Continue reading →

Gene Therapy 40

Gene Therapy Gene Trials Development 40

BioTech 365

APRIL 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: 3D biomaterial used as ‘sponge’ for stem cell therapy to reverse arthritis.A

Research 40

Research 40

BioTech 365

SEPTEMBER 29, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Orgenesis inks Koligo buyout to gain COVID-19 cell therapy.Orgenesis inks Koligo buyout to gain COVID-19 cell therapy ntaylor Tue, 09/29/2020 – 08:18 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

JANUARY 10, 2022

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol Myers buoys cell therapy interests with $3B biobucks deal with Bayer-backed Century, $70M upfront to ArsenalBio.Bristol Myers buoys cell therapy interests with $3B biobucks deal with … Continue reading →

Research 40

Research 40

BioTech 365

JANUARY 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gilead’s Kite Pharma unit nabs Marincola to head up its cell therapy research.Gilead’s Kite Pharma unit nabs Marincola to head up its cell therapy research badams Tue, … Continue reading →

Research 40

Research 40

BioTech 365

OCTOBER 25, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful.Juventas Cell Therapy closes a $63M funding round as it … Continue reading →

Research 40

Research 40

BioTech 365

OCTOBER 22, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Be Biopharma debuts with $52M to advance engineered B-cell therapies.Be

Engineer 40

Engineer Research 40

BioTech 365

MARCH 25, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Cell therapy player Fate Therapeutics sees CSO and 12-year veteran Shoemaker retire.Cell therapy player Fate Therapeutics sees CSO and 12-year veteran Shoemaker retire badams Thu, 03/25/2021 – … Continue reading → (..)

Research 40

Research 40

BioTech 365

NOVEMBER 10, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immatics’ cell therapy blasts solid tumors in phase 1, but durability spooks investors. Immatics’ cell therapy blasts solid tumors in phase 1, … Continue reading →

Research 40

Research 40

BioTech 365

JANUARY 28, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Merck bags solid tumor CAR-NKs from Artiva to push into cell therapy.Merck bags solid tumor CAR-NKs from Artiva to push into cell therapy ntaylor Thu, 01/28/2021 – … Continue reading →

Research 40

Research 40

BioTech 365

SEPTEMBER 22, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Emmecell exits stealth mode as FDA greenlights clinical trials of cornea cell therapy.Emmecell exits stealth mode as FDA greenlights clinical trials of cornea cell therapy amysokolow2020 Mon, … Continue reading →

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

Pharma Times

JULY 14, 2023

CAR-T cell therapy being researched among patients with relapsed or refractory B cell non-Hodgkin lymphoma - News - PharmaTimes

Research 108

Research 108

Pharmaceutical Technology

FEBRUARY 2, 2023

If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia. You can also subscribe here to receive email notifications when a new issue is available.

Gene Therapy 246

Gene Therapy Gene Pharma Companies Clinical Trials 246

BioTech 365

AUGUST 5, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis and a string of high profile backers fund next-gen Treg cell therapy startup GentiBio.Novartis and a string of high profile backers fund next-gen Treg cell therapy … Continue reading →

Research 40

Research 40

Fierce Pharma

SEPTEMBER 7, 2023

University of Pennsylvania spinout BlueWhale Bio has surfaced on a mission to smash bottlenecks in cell and gene therapy manufacturing. Cell therapy manufacturer BlueWhale Bio uncloaked Thursday with news it has raised $18 million in seed financing. The funding round was led by Danaher Corporation.

Gene Therapy 101

Gene Therapy Production Manufacturing Gene 101

BioTech 365

DECEMBER 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ASH: 2 years in, the survival data on J&J’s rival to Bristol Myers’ BCMA cell therapy are still growing.ASH: 2 years in, the survival data on J&J’s … Continue reading →

Research 40

Research 40

Drug Discovery World

MARCH 22, 2024

News round-up for 18-22 March by DDW Digital Content Editor Diana Spencer. This has been an interesting week for cell and gene therapies, with two landmark FDA approvals, two significant fundraising efforts and potentially ground-breaking study results in glioblastoma.

Gene Therapy 52

Gene Therapy In-Vivo FDA Approval Drugs 52

BioTech 365

JANUARY 5, 2022

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Intellia bags option on autoimmune CAR-T prospect, handing Kyverna rights to use CRISPR tech to create off-the-shelf cell therapy .Intellia

Research 40

Research 40

Pharma Times

JUNE 8, 2023

Laboratory space will accelerate the development of potentially life-saving cell therapies - News - PharmaTimes

Development 119

Development 119

Drug Discovery World

FEBRUARY 23, 2024

News round-up for 19-23 February by DDW Digital Content Editor Diana Spencer. In a breakthrough for advanced therapies, this week saw the FDA approve the first ever cell therapy for solid tumour cancers, but there were other significant developments in the cell and gene therapy space.

Gene Therapy 52

Gene Therapy Insulin FDA Approval Drugs 52

XTalks

JUNE 12, 2023

Bristol Myers Squibb (BMS), a multinational pharmaceutical company based in New York City, has announced that its new state-of-the-art cell therapy manufacturing facility in Devens, Massachusetts, has received approval for commercial production from the US Food and Drug Administration (FDA).

Manufacturing 95

Manufacturing Gene Therapy FDA Approval Gene 95

Pharmaceutical Technology

JANUARY 27, 2023

The chimeric antigen receptor T-cell (CAR-T) therapy axicabtagene ciloleucel has been recommended for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL) in adult patients who have previously received two or more lines of systemic therapy.

Gene Therapy 147

Gene Therapy Clinical Trials Clinical Trials Gene 147

Pharmaceutical Technology

MAY 12, 2023

Matinas announced the news in a May 10 statement. The news means the collaboration between the two companies lasted just over a year. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. In April 2022, BioNTech paid an upfront access fee to use Matinas’ LNC delivery platform technology.

Vaccination 130

Vaccination Vaccine In-Vivo In-Vitro 130